We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (11 March 2024) approved the medicine quizartinib (Vanflyta) to be used alongside chemotherapy as first line treatment for adults who have acute myeloid leukaemia (AML).
The epidemiology, symptoms, diagnosis and management of human T-cell lymphotropic virus types 1 and 2 (HTLV-1 and HTLV-2).
You must tell DVLA if you have leukaemia and a bus, coach or lorry licence - download the correct form if you need to let them know
This document contains a synopsis of causation occurring in leukaemia (chronic myeloid).
This document contains a synopsis of causation occurring in leukaemia (acute Myeloid, incorporating Myelodysplastic Syndromes).
You may need to tell DVLA if you have cancer - if you do, download the correct form to let them know
Wet line contamination involves the cross contamination of road fuel with rebated fuels, which will either be red diesel or kerosene.
How to spot enzootic bovine leukosis, what to do if you suspect it and measures to prevent its spread.
Guidance for hospitals, tissue establishments and fertility clinics for ensuring the quality and safety of human organs, tissues and cells (including reproductive cells).
Use these forms and guidance document to export cell lines for research use to Canada.
COMARE’s 14th report: review of the risk of childhood cancer near UK nuclear power plants from 1969 to 2004.
Automation is the future for manufacturing stem cells, says the Head of the Medicines and Healthcare products Regulatory Agency’s UK Stem Cell Bank (UKSCB) on its 20th Anniversary.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.